Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Merck & Co., Inc. ("Merck" or the "Company") and reminds investors of the April 14, 2025 ...

Biopharma giant MSD says it stands ready to pursue new approaches to advance public health in China after its GARDASIL ...

If you suffered losses exceeding $100,000 in Merck between February 3, 2022 and February 3, 2025 and would like to discuss ...

Levi & Korsinsky, LLP notifies investors in Merck & Co., Inc. ("Merck" or the "Company") of a class action securities lawsuit.

We believe investors with a long-term horizon should stay invested in MRK stock, while short-term investors should consider ...

Rising competitive pressure on the diabetes franchise and persistent challenges for its human papillomavirus vaccine, Gardasil in China remain overhangs. There are concerns about Merck’s ability ...

NEW YORK, NY / ACCESS Newswire / March 17, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn ...

Faruqi & Faruqi, LLP , a leading national securities law firm, is investigating potential claims against Merck & Co., Inc. (“Merck” or the“Company”) (NYSE: MRK) and reminds investors of the April 14, ...

Defendants claimed this was necessitated by the continued over-inflation of overall channel inventories as demand in China for Gardasil had “not recovered to the level we had expected.” ...

Merck and Bristol-Myers Squibb are key players in cancer treatment. Find out why MRK and BMY stocks have different prospects ...